Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion ...

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...

For anyone who wants to understand Globus Medical's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$279m due to ...

Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank. Studies have shown ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...

Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Globus Medical Inc. (NYSE:GMED), a leading player in the musculoskeletal healthcare sector, has been making waves in the medical device industry with its innovative robotic surgery platforms and ...

Globus Medical Inc. (NYSE:GMED), a leading player in the musculoskeletal healthcare sector, has been making waves in the medical device industry with its innovative robotic surgery platforms and ...